AvalehtCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Viimane sulgemishind
177,85 $
Tänane vahemik
160,01 $ - 180,19 $
Aasta vahemik
91,86 $ - 230,02 $
Turuväärtus
8,06 mld USD
Keskmine maht
1,02 mln
P/E suhe
-
Dividendimäär
-
Põhibörs
NYSE
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Käive | 1,03 mld | 0,59% |
Põhitegevusega seonduv kulu | 211,51 mln | 8,67% |
Puhastulu | 52,33 mln | −44,38% |
Puhaskasumimarginaal | 5,07 | −44,71% |
Puhaskasum aktsia kohta | 3,12 | 11,43% |
EBITDA | 327,04 mln | 26,18% |
Tõhus maksumäär | 26,22% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 182,82 mln | 2,01% |
Kogu vara | 7,56 mld | −4,88% |
Kõik kohustused | 4,16 mld | −0,34% |
Kogu omakapital | 3,40 mld | — |
Emiteeritud aktsiate arv | 49,21 mln | — |
Hinna ja väärtuse suhe P/B | 2,61 | — |
Varade tasuvus | 5,68% | — |
Kapitali tasuvus | 6,93% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | juuni 2025info | Y/Y muutus |
|---|---|---|
Puhastulu | 52,33 mln | −44,38% |
Põhitegevuse rahakäive | 204,60 mln | 5,72% |
Investeeringute raha | −37,34 mln | 39,65% |
Finantseerimise raha | −226,92 mln | 20,62% |
Raha ja raha ekvivalentide muutus | −46,99 mln | 70,17% |
Tasuta rahavoog | 228,38 mln | 54,82% |
Teave
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Tegevjuht
Asutatud
1947
Veebisait
Töötajate arv
19 400